“Minimalist” transcatheter aortic valve implantation during the COVID-19 pandemic: previously optional but now a necessity

EuroIntervention 2020;16:451-452. DOI: 10.4244/EIJV16I6A82

David Wood
David A. Wood, MD; Janarthanan Sathananthan, MBChB, MPH

Transcatheter aortic valve implantation (TAVI) may become the predominant therapy for the majority of patients with calcific aortic stenosis, irrespective of surgical risk1,2. This reflects an expansion in indications over time since the initial cases were performed over 15 years ago. Similarly, implantation technique and preprocedural, periprocedural and post-procedure care have evolved with many centres adopting a “minimalist” approach for TAVI cases.

In this issue of EuroIntervention, Costa and colleagues demonstrate the safety and efficacy of next-day discharge in a large series of unselected patients at a single centre3.

After adjustment, there were no differences in ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Coronary collaterals and myocardial viability in patients with chronic total occlusions

Latest news